At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Survival of the Probiotic Lacticaseibacillus Paracasei Strain Shirota (LcS) in the Gastrointestinal Tract of Generally Healthy Adults
In Brief
A clinical study evaluating Drink one bottle of Yakult a day for Healthy. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The objective of this study is to investigate the survival of Lacticaseibacillus paracasei strain Shirota (LcS) in the human gastrointestinal (GI) tract after consumption of probiotics fermented milk product containing 8x10\^9 LcS. This study is a single-arm, open-label study with a 14-d run-in (baseline), 14-d consumption period, and 14-d follow-up. Participants will maintain habitual dietary and lifestyle practices with the exception of avoiding fermented foods and beverages throughout the 42-d trial. The number of live LcS in fecal samples will be assessed after 14 d consumption of a fermented milk product.
Study Details
Timeline
Interventions
Yakult is a branded probiotic drink with 8x10\^9 CFU Lacticaseibacillus paracasei strain Shirota